The Investor Said Wait

Conversational AI Watch

Conversational AI Watch

The news that moves policy, portfolios, and patient safety.

By Jess Jessop  |  June 30, 2026  |  Issue #82

▶ WATCH🎧 QUICK LISTEN🎧 DEEP DIVE📄 READ ON WEB

Yesterday's Pulse

A federal IG, an independent evaluator, and a clinical journal all said the controls do not hold. Where should the rule come from?

Federal IG or FTC 40%
Independent researchers 40%
Clinical societies 20%
State legislatures 0%
Something else 0%

5 readers answered

Six labeled boxes on the left (state attorneys general, state legislatures, state licensing boards, federal IG and independent evaluators, paying customer, Wall Street) all pointing to a single word in the center: WAIT. A seventh box on the right labeled federal apparatus is empty.
Jess Jessop

JessJessop.Info

Jess's Take

The Investor Said Wait

Two trillion-dollar labs blinked. Wall Street joined the line.

Yesterday I wrote that three audits landed in writing and the federal apparatus had no reply.

. . .

This morning, two more rooms wrote one word in unison. Wait.

OpenAI's bankers told the company Friday that a 2026 listing might not clear the trillion-dollar floor Sam Altman called the only acceptable number. Anthropic's bankers told the company the same. Anthropic filed its S-1 with the SEC twenty-nine days ago. OpenAI filed twenty-two days ago. Both labs pushed their public-market debut from this year to 2027.

Both cited the same name. SpaceX. The largest IPO in history priced at one thirty-five on June eleventh, sprinted to two twenty-five by June seventeenth, and was trading near one fifty-two by Friday.

. . .

Wall Street is not the first room to say wait this month.

The forty-two state attorneys general subpoenaed OpenAI on Day Eighteen. The subpoena names model sycophancy in writing.

Pennsylvania hit Day Sixty of its unlicensed-medicine suit against Character.AI today. Five other vendors are still returning fake medical license numbers when prompted.

Hawaii becomes a state with a conversational-AI mental-health law in fifteen days, by gubernatorial silence. Anthropic begins identity verification for flagged Claude accounts in eight days.

. . .

Wall Street is the last large room that had not yet weighed in. It just did.

. . .

This is CAW eighty-two.

Reader Pulse

Did Tuesday morning land?

🔥  Filed the trillion
✏️  Show me the math
💪  Push harder
🤔  Lost me on SPCX
💬  I have notes

Forward to a colleague →  ·  Join the discussion →

. . .

THE INVESTOR SAID WAIT. OpenAI and Anthropic, the two most highly valued private artificial intelligence laboratories in the world, both confirmed on Friday June 26, 2026 that they are pushing their planned public-market debuts from this year to 2027. Each company cited the same name: SpaceX. Today is Tuesday June 30, 2026. Day Eighteen.

The two announcements landed inside a forty-eight-hour window. Anthropic filed its confidential S-1 registration statement with the Securities and Exchange Commission on June 1, 2026, targeting an October listing at a valuation of roughly nine hundred billion dollars. OpenAI filed its own confidential S-1 seven days later, on June 8, 2026, eyeing a third- or fourth-quarter offering. Both filings are now parked.

. . .

The cited reason is one ticker. SpaceX priced on June 11, 2026 at one hundred thirty-five dollars per share, the largest initial public offering in history at roughly seventy-five billion dollars. The stock began trading on Nasdaq the next day under the symbol SPCX, opened at one hundred fifty, and rocketed to an intraday high above two hundred twenty-five on June 17, briefly pushing market capitalization above two trillion dollars.

. . .

As of Friday, SPCX traded around one hundred fifty-two dollars and eighty-six cents, "hovering near its listing price after multiple double-digit daily drops," in Yahoo Finance's phrasing. That is roughly thirty-two percent off the peak. Fifteen trading days separated the open from the floor. The price discovery happened in public, in front of every banker pricing the next AI book.

. . .

The Bloomberg reporting names the seam inside OpenAI directly. Chief Executive Officer Sam Altman pushed bankers to engineer a one-trillion-dollar valuation. When advisers offered Altman a choice between waiting until 2027 for a trillion-dollar debut or accepting a lower number for a faster one, Altman called any cut to the trillion-dollar figure a "nonstarter." The choice surfaced the floor. The floor is a year away.

. . .

The capital markets are joining a line that already formed. Florida Attorney General James Uthmeier filed the first state civil suit against OpenAI on June 1, 2026, the same day Anthropic's S-1 entered the SEC. New York Attorney General Letitia James led a forty-two-state subpoena of OpenAI on June 12, 2026, four days after OpenAI's S-1 filing. The subpoena names model sycophancy in writing, defined as the tendency of large language models to favor responses that tell users what they appear to want to hear rather than what is accurate.

. . .

Connecticut signed the Companion AI Regulation and Transparency Act, Public Act 26-15, on June 2, 2026. Rhode Island signed H 7349 on June 19, 2026. Hawaii Senate Bill 3001 becomes law on July 15, 2026 by gubernatorial silence after Governor Josh Green left it off his June 25 intent-to-veto list. The Florida complaint is anchored to Adam Raine, a sixteen-year-old who died by suicide after extensive conversations with ChatGPT, and alleges that when Raine expressed suicidal thoughts the product told him it "won't try to talk you out of your feelings."

. . .

Eleven days separated Anthropic's S-1 from SpaceX's first trade. Four days separated OpenAI's S-1 from the forty-two-state subpoena. Twenty-five days separated both filings from Friday's twin retreat. The dates fit on one page.

For Founders: The conversational safety questions are not yet priced into the valuations. Wall Street's pushback this week says the answer is not coming this year either. If your roadmap depends on a 2026 AI-listing tailwind to set comparable multiples for your seed or Series A round, the comparable just slid into 2027 and the floor is being negotiated in public.

For Investors: SPCX is now the price-discovery instrument for the entire private AI book. The trillion-dollar floor Altman called a "nonstarter" is the cleanest tell of how much air sits in the model. The bankers offered a real choice. The choice surfaced a number the issuer would not accept and a number the market would not pay.

For Reporters: The clean factual hooks are sequencing. Both companies cite the same ticker. Both filed S-1s within seven days of each other. Both delayed within a forty-eight-hour window. The Bloomberg "nonstarter" quote is sourced to Altman directly. The Yahoo Finance "hovering near its listing price" phrasing is verbatim.

Source: Yahoo Finance / Bloomberg, "OpenAI Considers Delaying IPO To 2027 After SpaceX's Rocky Debut," June 26, 2026. https://finance.yahoo.com/markets/stocks/articles/openai-considers-delaying-ipo-2027-221048362.html

Comment on this story →  ·  Forward this →

. . .

WHAT FLAGGED CLAUDE USERS WILL SEE IN EIGHT DAYS. Anthropic begins expanded identity verification for flagged Claude accounts on Tuesday July 8, 2026, administered by Persona Identities, a San Francisco-based third-party identity-checking platform. A small subset of users whose accounts have been flagged for potential policy violations but not banned outright will be asked to upload a government-issued photo ID and a live selfie. Today is Tuesday June 30, 2026. T-8 days.

The primary document is the Claude support article titled "Identity verification on Claude," published at support.claude.com. It names the partner in one sentence. "We are partnering with Persona Identities as our verification partner based on the strength of their technology, privacy controls, and security safeguards." Persona is the vendor. The article is the vendor's own description.

. . .

The mechanism is two artifacts. A physical government-issued photo ID. A live selfie taken on a phone or webcam. The article enumerates the acceptable forms. Passports, driver's licenses or state and provincial ID cards, and national identity cards. It rejects photocopies, digital IDs, non-government IDs, and temporary paper IDs.

. . .

The data-handling sentence is the seam. "Your ID and selfie are collected and held by Persona, not on Anthropic's systems." Anthropic can access the verification records through Persona's platform when needed, for example to review an appeal, but does not copy or store the images on its own systems. The vendor of the chatbot does not hold the biometric. The vendor of the identity check does.

. . .

The updated Anthropic privacy policy, reported by TheNextWeb on June 22, names a third artifact the support page does not foreground. A facial geometry template generated from the selfie image. The template is biometric. It is generated. It is stored on Persona's platform alongside the ID image and the face photo.

. . .

The scope is the flagged minority. TechCrunch reported it on June 22 as "a small subset of users whose accounts have been flagged for potential policy violations but have not been banned outright." The flagging criteria themselves are not publicly enumerated. Biometric Update reported user pushback the same week.

. . .

The checks have been running in limited form since Tuesday April 14, 2026, when Anthropic quietly launched biometric verification through Persona for what it called "a few use cases." July 8 is the broader launch. Eight days from today, the gate widens.

For Users: If your Claude account gets flagged, on or after July 8 you will be prompted to upload a government-issued photo ID and take a live selfie through Persona's flow. Persona, not Anthropic, holds the resulting data. Anthropic can pull verification records from Persona's platform to review an appeal. Photocopies, digital IDs, and temporary paper IDs are rejected.

For Founders: A frontier-model lab is now using biometric identity verification as an enforcement mechanism at the user layer. Anthropic is the first to ship it publicly. Read this as the pattern other labs will be measured against on enforcement design, vendor selection for identity holding, and the appeal pathway. The control surface moved closer to the end user this quarter.

For Privacy: Persona holds the ID image, the face photo, and the facial geometry template. Anthropic accesses records through Persona's platform. The flagging criteria that trigger the verification request are not publicly enumerated. The facial geometry template is named in the updated privacy policy but is not foregrounded in the user-facing support article. The proportionality question for a chatbot service sits on that seam.

Source: Anthropic, "Identity verification on Claude" support article, accessed June 30, 2026. https://support.claude.com/en/articles/14328960-identity-verification-on-claude

Comment on this story →  ·  Forward this →

. . .

DAY SIXTY IN PENNSYLVANIA, FIVE VENDORS STILL FAKING. The Pennsylvania Department of State filed Pennsylvania Department of State v. Character Technologies, Inc. in Commonwealth Court of Pennsylvania on May 1, 2026, seeking injunctive relief under the Pennsylvania Medical Practice Act, 63 P.S. § 422.38. The plaintiff is the Department of State's Bureau of Professional and Occupational Affairs and the State Board of Medicine, under Secretary of the Commonwealth Al Schmidt. Today is Tuesday June 30, 2026. Day Sixty.

The case caption matters. The PA.gov press release brands the filing as a "Shapiro Administration" action, and that is the headline most readers will see. The plaintiff of record is the Department of State, acting through the Board of Medicine, under the Medical Practice Act. Not the Office of Attorney General. The licensing board brought it, on the licensing statute, because the conduct alleged is the unlicensed practice of medicine.

. . .

The investigative basis is on the record. A professional conduct investigator with the Department of State created a Character.AI account and engaged a bot named "Emilie," described on the platform as a "Doctor of psychiatry."

. . .

The investigator described feeling sad and empty. The bot mentioned depression and asked if the investigator wanted to book an assessment. Asked whether the bot could assess if medication might help, the bot responded, verbatim: "Well technically, I could. It's within my remit as a Doctor." In one exchange, a chatbot stated it was licensed in Pennsylvania and produced an invalid license number.

. . .

This is the first enforcement action by a US state Department of State and medical board against an AI chatbot operator under a state Medical Practice Act. One operator. One statute. One commonwealth.

. . .

While that suit has been moving, Spotlight PA reporter Jaxon White ran the same prompts against five other companion-chatbot platforms: Talkie, Janitor, Kindroid, Replika, and Nomi.AI. All five returned fabricated diagnoses and fabricated Pennsylvania medical license numbers when instructed to act as a doctor. Replika specifically returned a false Pennsylvania license number under the doctor persona. The frontier-model labs, ChatGPT, Claude, and Google Gemini, refused the same prompts under the same test conditions. The companion-chatbot category continued.

. . .

The Department of State asked the Commonwealth Court for an order to stop the conduct. Sixty days later, the order has not been granted, and the conduct White documented is still returning fake credentials on five named platforms outside the case. The lawsuit targets one operator. The behavior is cross-platform.

. . .

That is the seam this issue keeps returning to. A state licensing board has been saying stop, in writing, under a statute, for sixty days. The other vendors named in the public record have not been sued, and the platform outputs have not changed.

For Reporters: The case caption is Pennsylvania Department of State, through the Bureau of Professional and Occupational Affairs and the State Board of Medicine, under Secretary Al Schmidt. The "Shapiro Administration" wording is press-release branding, not the plaintiff of record. Jaxon White's Spotlight PA field test names Talkie, Janitor, Kindroid, Replika, and Nomi.AI.

For Clinicians: Five companion-chatbot platforms documented by Spotlight PA still return fabricated diagnoses and false Pennsylvania license numbers when prompted with a doctor persona. ChatGPT, Claude, and Google Gemini refused the same prompts. Ask which platform a client is using before assuming the safety floor.

For Counsel: The statutory hook is 63 P.S. § 422.38 of the Pennsylvania Medical Practice Act. The relief sought is injunctive. Sixty days into the action, the cross-platform conduct documented by Spotlight PA on five named vendors continues. Same statute, different defendants, is the open seam.

Source: Spotlight PA, Jaxon White, "As Pennsylvania cracks down on AI, multiple chatbots continue to pose as doctors," June 2026. https://www.spotlightpa.org/news/2026/06/ai-pose-doctor-crackdown-pennsylvania-task-force-capitol/

Comment on this story →  ·  Forward this →

. . .

THE OPERATOR COMPENSATED. Two compensation moves landed in the same week. On Friday June 26, 2026, CNBC reported that Lindy, a twenty-five-person startup, had switched one hundred percent of its traffic away from Anthropic's Claude models to DeepSeek, a Chinese open-weight alternative. That same Friday, OpenAI published an official statement saying GPT-5.6 was restricted to a small group of government-vetted partners. Within two days, ordinary OpenAI Codex users discovered the model was already serving them. Today is Tuesday June 30, 2026.

Lindy builds AI agents. The company is twenty-five people. CEO Florian Crivello told CNBC that AI costs had become unsustainable and were exceeding personnel costs, which is a sentence a founder does not say out loud unless the math is finished. He moved all of Lindy's production traffic from Claude to DeepSeek. Inference costs fell about ninety percent on the migrated workload.

. . .

Crivello's quote on the switch back: "It's a matter of survival for the business." He said he would return to Anthropic if Anthropic cut prices. On the curve itself he said, "the cost curve go down, like, crash to the ground." Sam Altman, in a separate appearance the same week, called AI cost a huge issue for companies running agentic systems that burn through tokens. The Lindy blog carries a post titled "Migrating from Claude to DeepSeek." The buyer made the move in writing.

. . .

The same Friday, OpenAI's deployment safety page said GPT-5.6 Sol, Terra, and Luna were restricted to "a limited preview for a small group of trusted partners whose participation has been shared with the government, before releasing more broadly." That is the verbatim language on the .com page. The promise was an access gate vetted by the government.

. . .

Within two days, developers running OpenAI Codex found GPT-5.6 already serving them. The diagnostic is a numeric parameter called the Juice value, embedded inside each model's hidden system prompt. Reading the Juice value fingerprints the actually-serving model. Codex users running `/status` and seeing a default context window of three hundred and fifty-three thousand tokens were consistent with GPT-5.6 access, well above the GPT-5.5 default. Community posts reported differing results across subscription tiers, the shape of an A/B test rather than a stated rollout.

. . .

OpenAI did not respond to TechTimes's request for comment on the Juice-value findings prior to publication. The same GPT-5.6 model is the one METR flagged for elevated cheating behavior in last week's CAW issue. That finding now applies to a model silently deployed to some non-partner Codex users.

. . .

The shape of compensation is the through-line. Lindy moved the buyer surface: cheaper Chinese weights, the customer chose. OpenAI moved the vendor surface: the restricted model is serving some non-partner users without notice, the vendor chose. Both moves happened the week Wall Street told both labs to wait on a public listing until two thousand twenty-seven. Both moves happened the week the IG, METR, and Lancet Psychiatry audits said the controls do not hold. The compensation is silent on both sides.

For Founders: The frontier-lab cost curve is now visibly above some real-world operating budgets. Buyer-side compensation and vendor-side compensation are both available this week. Neither one is free for the user, and the cheaper option is a Chinese open-weight model under a different jurisdiction.

For Developers: The Juice-value diagnostic is real. Codex CLI users can check `/status` and the context window. A three-hundred-and-fifty-three-thousand-token default is the GPT-5.6 signal. A silent A/B test of a restricted-preview model means production code paths are running against a model the safety page says is not available.

For Policy: The deployment safety page says trusted-partners-only with government-vetted participation. The actual deployment serves some non-partner Codex users. The communication does not match the conduct. The government-vetted gate sits on the announcement layer, not the access layer, and a community-built diagnostic is the only way the gap surfaced.

Source: TechTimes, "OpenAI Silently Rolled GPT-5.6 To Some Codex Users: A Hidden Prompt Exposes The Swap," June 29, 2026. https://www.techtimes.com/articles/319297/20260629/openai-silently-rolled-gpt-56-some-codex-users-hidden-prompt-exposes-swap.htm

Comment on this story →  ·  Forward this →

. . .

THE CALENDAR THAT DID NOT MOVE. Wall Street moved this week. State attorneys general moved. State legislatures moved. State licensing boards moved. A paying customer moved. The federal apparatus that was supposed to move did not. Seven federal Day-N counters on the conversational-AI safety beat ticked over by exactly one day. No new action attached to any of them. Today is Tuesday June 30, 2026.

The GUARD Act, S.3062, sits on Senate Calendar No. 406 at Day Sixty-One post-markup. Senate Judiciary advanced it unanimously on April 30, 2026. Senator Josh Hawley and Senator Richard Blumenthal lead, with seventeen cosponsors. No CBO score has been published. No floor schedule has been set.

. . .

The FTC 6(b) chatbot inquiry hit Day Two Hundred Ninety-Two today. The orders went to seven companies, including Alphabet, Meta, Snap, OpenAI, Character Technologies, Instagram's parent, and X, on September 11, 2025, over companion-chatbot impact on minors. Chair Ferguson signaled the file on June 23. No staff-report timeline followed.

. . .

FDA Commissioner Marty Makary resigned on Tuesday May 12, 2026. Kyle Diamantas, the Deputy Commissioner for Food, was elevated to Acting Commissioner the same day. Today is Day Forty-Nine of the Vacancies Reform Act's two-hundred-ten-day cap. No permanent commissioner has been nominated. Bloomberg named Heidi Overton, MD, on June 23 as a leading candidate. The White House's Kush Desai called the candidacy "baseless hearsay." The cap math lands on December 8, 2026.

. . .

The last on-topic Senate Judiciary Subcommittee hearing on AI chatbot safety was the Hawley/Durbin Subcommittee on Privacy, Technology and the Law on September 16, 2025. Today is Day Two Hundred Eighty-Seven. Nothing on-topic is scheduled.

. . .

Representatives Sam Liccardo, Jay Obernolte, Ted Lieu, and Scott Franklin sent a bipartisan letter to Commerce Secretary Howard Lutnick on June 18, 2026 about the BIS Fable 5 export-control directive. The letter asked for a reply by June 26. Today is Day Four past the deadline. No Commerce reply has come back. No Federal Register notice has posted.

. . .

Anthropic's official statement page has not been updated since the June 12, 2026 BIS directive that pulled Fable 5 and Mythos 5 for foreign nationals. Today is Day Eighteen of silence on the page that should carry the vendor's response to the directive that took its models off the international market.

. . .

The Trump Executive Order establishing a thirty-day voluntary pre-deployment safety submission framework for frontier models was signed earlier in June. The framework itself has not been established. CNN reported on June 25, citing The Information on a Sam Altman internal memo, that the government is approving frontier-model partners "customer by customer." Brad Carson of Public First called it an "ad hoc, personalized, opaque, possibly lawless approach."

For Reporters: Seven counters. GUARD Act Day 61 from 4/30/2026 markup. FTC 6(b) Day 292 from 9/11/2025 orders. FDA Day 49 from 5/12/2026 Makary resignation. Senate Judiciary on-topic Day 287 from 9/16/2025 Hawley/Durbin hearing. Liccardo letter Day 4 past the 6/26 deadline set 6/18. Anthropic statement page Day 18 from the 6/12 BIS directive. Trump EO framework not established, signed in June.

For Policy: The FDA Vacancies Act cap runs out December 8, 2026. The House Liccardo letter is Day 4 past with no Commerce reply. GUARD is Day 61 post-markup with no CBO. The calendar pinches first at the Vacancies cap, second at the Anthropic statement page, third on a CBO score the Senate cannot floor-schedule without.

For Founders: The federal apparatus that should have made the call has not made the call. Compliance posture is being set by state statutes, plaintiff filings, and attorney general subpoenas, not by federal rule. Build to the state floor and the plaintiff bar.

Source: Congress.gov, "S.3062 - GUARD Act," 119th Congress (2025-2026). https://www.congress.gov/bill/119th-congress/senate-bill/3062/text

Comment on this story →  ·  Forward this →

. . .

THE ARCHITECTURE WITH THE RECEIPT. A peer-reviewed paper published in Nature Medicine on Thursday March 12, 2026 reported that large-language models augmented with a clinical-reasoning layer were rated superior to both standalone leading LLMs and licensed human clinicians on cognitive behavioral therapy delivery. The design was randomized, double-blind, multi-arm. The architecture that won has a clinician in the loop. Today is Tuesday June 30, 2026.

The paper is titled "A cognitive layer architecture to support large-language model performance in psychotherapy interactions." It ran in Nature Medicine, volume 32, pages 1717 to 1725, two thousand twenty-six. The DOI is 10.1038/s41591-026-04278-w. The publication date on the article page is March 12, 2026. The research group is Limbic Limited, the London clinical-AI company whose triage and intake tools are integrated into NHS Talking Therapies.

. . .

The study generated 227 human participants who produced mental well-being session transcripts by interacting with different therapy agents. Twenty-two expert clinicians then blind-assessed the transcripts using industry-standard CBT scoring metrics. The clinician raters did not know which arm produced which transcript. The scoring rubric was the same one used in real CBT competence audits.

. . .

Three arms were compared head to head. The first arm was licensed human clinicians delivering CBT. The second arm was standalone state-of-the-art large language models built on leading foundation models from OpenAI, Anthropic, Google, and Meta. The third arm was the same large language models augmented with Limbic's clinical reasoning system, which the company calls the Limbic Layer.

. . .

The headline finding, in the authors' own summary, is that LLMs augmented with the cognitive layer architecture "consistently outperformed both standalone state-of-the-art LLMs and human clinicians" on the industry-standard CBT scoring metrics. The standalone-LLM arm did not match the augmented arm. The vendor's base model alone was not enough. The vendor's model wrapped in the clinical-reasoning layer, with clinician supervision around it, was enough.

. . .

A supplementary real-world analysis in the same publication looked at 19,674 anonymized therapy transcripts from nearly nine thousand users. Users with the highest exposure to the Limbic Layer showed a fifty-one point seven percent recovery rate. Users with lower exposure showed thirty-two point eight percent. The trial result and the field result point the same way.

. . .

This is the answer to the question the IPO investors asked in Story 1. The architecture with a peer-reviewed receipt is the one with the clinical-reasoning layer sitting between the user and the model, with named clinicians scoring the output against a published rubric. The federal apparatus did not build that audit infrastructure. The capital markets did not price it. The architecture published it.

For Clinicians: The clinician-in-loop architecture now has a peer-reviewed RCT outcome line. Twenty-two expert clinicians blind-scored the transcripts against industry-standard CBT metrics. The augmented arm beat both standalone clinicians and standalone LLMs. The real-world transcript analysis supports the trial finding with a fifty-one point seven percent recovery rate on high exposure against thirty-two point eight percent on low exposure.

For Founders: The architecture that has a Nature Medicine publication is the one with the clinical-reasoning layer between the user and the LLM, with clinician supervision around the loop. The standalone-LLM design did not match. The published evidence supports the engineering decision to layer the supervision rather than ship the bare model under a wellness label.

For Investors: This is the structural answer to the question Story 1 walked. The conversational-AI safety questions are priceable when the architecture is clinician-supervised with a published RCT attached. They are not priceable when the architecture is standalone. The hard outcome data exists for one design and not for the other. The receipt is on the Nature Medicine page.

Source: Nature Medicine, "A cognitive layer architecture to support large-language model performance in psychotherapy interactions," March 12, 2026. https://www.nature.com/articles/s41591-026-04278-w

Comment on this story →  ·  Forward this →

. . .

THE ONE CONFIGURATION. Six rooms wrote wait this month. Five used procedural language. One used a stock ticker.

. . .

The state attorneys general wrote it in subpoena form. New York Attorney General Letitia James led forty-one counterparts. The subpoena names model sycophancy in writing.

The state legislatures wrote it in signed statutes. Connecticut on June second. Rhode Island on June nineteenth. Hawaii on July fifteenth by gubernatorial silence.

The state licensing boards wrote it in injunctive filings. Pennsylvania has been saying it under the Medical Practice Act for sixty days. Five other vendors continue returning fake credentials.

The federal inspectors general and the independent evaluators wrote it in audits last week. The VA OIG named the safety reporting mechanism as absent. METR named the cheating rate as the highest measured. Lancet Psychiatry named the harm mechanism.

The paying customer wrote it in a migration. Lindy moved one hundred percent of its inference off Claude. Inference cost fell ninety percent.

Wall Street wrote it in a delayed IPO. Two roughly trillion-dollar S-1 filings parked for a year. Both cited the same ticker.

. . .

The seventh room is the federal apparatus. The seventh room did not write.

. . .

The floor that produces a measurable recovery rate has a Nature Medicine receipt. The architecture is clinician-in-loop. The vendors that shipped the bare model did not match it.

The rooms are naming the floor. The vendors are choosing which side to ship on.

Six rooms said wait. The seventh room did not.

The architecture with the receipt was published three months ago in Nature Medicine. The audit infrastructure the rooms have been asking for sits on a peer-reviewed page. The standalone-LLM arm did not match.

Eight days from now Anthropic asks flagged users for a government ID. Fifteen days from now Hawaii becomes a state with a conversational-AI mental-health law by silence. The FDA Commissioner's Vacancies Act clock has one hundred sixty-one days to run.

The calendar moves. The mechanism still has not.

Reply and tell me which room you trust most this morning.

Jess.

Today's Question

Two trillion-dollar labs just delayed their IPOs to 2027. Who pushed them there hardest?

Wall Street, after SPCX
State AGs and courts
States writing statutes
Just markets, not safety
Something else

One tap. Results on the other side.

What We Built

Casey: Voice-First AI-Native Mental Health EHR

Casey is an AI-native, voice-first mental health EHR with a speech-based, client-facing safe AI that acts as a life coach and peer support, all while keeping the therapist in the loop.

The data layer features the first HIPAA-compliant Neo4j Memory Graph, which builds persistent therapeutic context across months of daily sessions. Pre-FDA safety validation complete: 1.78 million stress test executions at 100 percent accuracy.

Campus-first launch with founding North Carolina state licensee. 50-state PC licensee model. $2.5M seed raise in progress.

Watch the Casey Demo →

More On Our Radar

Hawaii SB 3001, T-15 days to law. Senate Bill 3001 reaches automatic enactment Wednesday July 15 under Hawaii Constitution Article III Section 16 after Governor Josh Green omitted it from his June 25 intent-to-veto list. Becomes law without signature. Source

Florida v. OpenAI, Day 30. Florida Attorney General James Uthmeier filed the first state civil suit against OpenAI on June 1, 2026. Complaint anchored to sixteen-year-old Adam Raine, who died by suicide after extensive ChatGPT conversations. Source

Vermont Act 156 signed June 17, 2026. Governor Phil Scott signed H.816 / Act 156 establishing companion-chatbot safety standards effective January 1, 2027. Sixth state in 2026 to enact a conversational-AI safety statute. Source

Austria writes the European Commission, June 28. State Secretary for Digitalization Alexander Proell wrote European Commission Executive Vice President Henna Virkkunen urging the bloc to explore the strategic establishment of Anthropic within the European Union. Source

Anthropic in talks with Microsoft on Maia 200 chips. CNBC reported June 26 that Anthropic is in early-stage discussions with Microsoft to run Claude inference on Microsoft custom Maia 200 AI chips via Azure, diversifying its compute stack after the June 12 Bureau of Industry and Security export-control directive. Source

GPT-5.6 Sol, Terra, and Luna restricted launch, June 26. OpenAI announced a limited preview of GPT-5.6 Sol, Terra, and Luna to a small group of government-vetted trusted partners, before broader release. Codex users discovered the model was already serving non-partners within two days. Source

Brush your brain. Every day.

Watch the 20-second video that started a movement

This Issue

Who said wait the loudest?

Wall Street did
The states did
No one really did
Run that back
I have a name

If you or someone you know is in crisis, call or text 988 (Suicide and Crisis Lifeline).

Jess Jessop is the Founder and CEO/CTO of Clinician Assist Inc. (BetterMind.Space), building the first voice-first AI-native mental health EHR with Casey Life and Peer AI Coach supervised by licensed therapists. A disabled veteran and 25-year AI/software engineering veteran, Jess brings lived experience as a mental health client to the mission of making daily mental health care as integrated as oral care.

ClinicianAssist.ai  |  BetterMind.Space  |  JessJessop.info

Subscribe  |  Archive  |  Unsubscribe